CHRS EBITDA Margin
Coherus Oncology Inc · EBITDA Margin
CHRS EBITDA Margin
Latest reported-291.46%period ending
CHRS EBITDA Margin (-1647.34% → -291.46%)
Annual ebitda margin
High-resolution chart · PNG
CHRS ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -403.5829% | |
| 22.8278% | |
| -75.3911% | |
| -121.1043% | |
| -79.8304% | |
| 33.5756% | |
| 31.1811% | |
| -13,137.2751% | |
| -14,481.7481% | |
| -61.4457% | |
| -739.1099% | |
| -265.9133% | |
| -1,742.5663% | |
| -1,647.3407% |